Johnson & Johnson has agreed to the divestiture of its entire trauma business in the European Economic Area to remove overlap in trauma devices as a result of the acquisition. On that basis, the Commission cleared the transition.
A likely recipient of the company’s DePuy trauma business is Biomet, which placed a $280 million offer earlier this year.
More Articles on Orthopedic Devices:
Medtronic Launches Power Instruments for Spinal Surgery
Surgeons Report No Improvement in Joint Reconstruction Market
Tornier Consolidates Facilities to Save More Than $2M Per Year
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.